Metastasis (Routes and Common Sites)
USMLE Step 1 trap: Misclassifies prostate bone metastases as osteolytic rather than osteoblastic. Prostate cancer characteristically produces osteoblastic (sclerotic) bone metastases, appearing as dense lesions on X-ray.
Metastasis is the defining feature of malignancy — benign tumors don't do it. For USMLE Step 1, you need to know the four routes (lymphatic, hematogenous, transcoelomic/seeding, direct extension), which tumor types prefer which route, and where specific cancers like to land. The exam tests this at multiple levels: pure recall (which primary causes osteoblastic mets?), clinical application (a patient with known lung cancer develops new brain lesions — what's happening?), and passage interpretation (a vignette describes X-ray findings of dense vertebral lesions in a man with urinary symptoms — you need to connect prostate cancer to osteoblastic disease). This is a high-yield topic that shows up repeatedly, often embedded in longer clinical vignettes.
The trickiest part isn't memorizing the routes — it's keeping the carcinoma/sarcoma distinction straight, and knowing which bone metastases are lytic vs. blastic. Students routinely flip these. Most bone mets are osteolytic (kidney, thyroid, lung, breast, multiple myeloma), but prostate is the classic exception that goes blastic. Breast can actually do both. If you don't have that nailed, you'll miss a 'free' question.
The other high-yield angle is understanding WHY certain tumors go to certain organs. Liver mets from colorectal cancer make sense once you know portal venous drainage — the colon drains into the portal system, which goes straight to the liver. Lung cancer seeds the brain because pulmonary venous blood goes directly to systemic circulation, bypassing the liver filter. USMLE Step 1 rewards mechanistic thinking, not just list memorization. Build the logic and the lists become easier to recall under pressure.
Common misconceptions
What the exam tests
- Know the four routes of metastasis (lymphatic, hematogenous, transcoelomic/seeding, direct extension) and which tumor types characteristically use each — carcinomas favor lymphatic spread first, while sarcomas favor hematogenous spread.
- Identify which primary cancers metastasize to bone and whether they produce osteolytic (destructive) or osteoblastic (sclerotic/dense) lesions — prostate is the classic osteoblastic exception; most others, including kidney, thyroid, and lung, are osteolytic.
- Recognize the most common primary sources of brain metastases — lung cancer is number one overall, followed by breast, melanoma, renal cell, and colon — and apply this when a vignette presents new CNS lesions in a patient with known cancer.
- Identify the most common primary tumors that metastasize to the liver — colorectal, stomach, pancreas, breast, and lung — and understand that liver metastases vastly outnumber primary hepatocellular carcinoma in clinical settings, driven by portal venous drainage for GI tumors.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →